Thank you for providing us with the opportunity to respond to Dr. Peverill’s comment concerning our article entitled “Cardiac involvement assessment in systemic sclerosis using speckle tracking echocardiography: a systematic review and meta-analysis”. We also acknowledge and appreciate Dr. Peverill’s time spent reading our article and providing his comments to help us strengthen the article.
As proposed by Dr. Peverill and also stated in the article, our systematic review was conducted because of results from related studies were controversial. Based on the meta-analysis results, we found left ventricular (LV) global longitudinal strain (GLS) was lower in SSc patients than in healthy control subjects. We are sorry we included multiple sclerosis in the study by mistake. We will correct it as soon as possible with the help of our editors. As for the reported large standard deviation (SD) of GLS of 8.9% in the control group 1, we have carefully reviewed the article again, and this value has been mentioned many times and is difficult to identify as an error. Moreover, as suggested by Dr. Peverill, we will present the result with the study excluded in the supplementary file.
As Dr. Peverill suggests, age and sex may affect GLS. The effects of age and sex on the results of SSc and control groups need to be considered, however most studies include age- and sex- matched control groups [2-7], which may reduce the effect. In our study, we also perfor...
Thank you for providing us with the opportunity to respond to Dr. Peverill’s comment concerning our article entitled “Cardiac involvement assessment in systemic sclerosis using speckle tracking echocardiography: a systematic review and meta-analysis”. We also acknowledge and appreciate Dr. Peverill’s time spent reading our article and providing his comments to help us strengthen the article.
As proposed by Dr. Peverill and also stated in the article, our systematic review was conducted because of results from related studies were controversial. Based on the meta-analysis results, we found left ventricular (LV) global longitudinal strain (GLS) was lower in SSc patients than in healthy control subjects. We are sorry we included multiple sclerosis in the study by mistake. We will correct it as soon as possible with the help of our editors. As for the reported large standard deviation (SD) of GLS of 8.9% in the control group 1, we have carefully reviewed the article again, and this value has been mentioned many times and is difficult to identify as an error. Moreover, as suggested by Dr. Peverill, we will present the result with the study excluded in the supplementary file.
As Dr. Peverill suggests, age and sex may affect GLS. The effects of age and sex on the results of SSc and control groups need to be considered, however most studies include age- and sex- matched control groups [2-7], which may reduce the effect. In our study, we also performed a meta-regression to explore the relationship between myocardial strain parameters and demographic variables such as age and sex, but the results were not significant.
As noted in Dr. Peverill's comments, there was a statistically significant difference in GLS between patients with SSc and controls, but probably only a small difference on average, which may be related to the severity of the disease. Because cutoff values were affected by many factors, more high-quality studies are needed to make the conclusions more reliable. More evidence is needed on the clinical application of GLS in SSc. We look forward to additional studies in the future to confirm the benefits of GLS measurements in assessing cardiac involvement in SSc.
1.Zairi I, Mzoughi K, Jnifene Z, Kamoun S, Jabeur M, Ben Moussa F, Kraiem S. Speckle tracking echocardiography in systemic sclerosis: A useful method for detection of myocardial involvement. Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):226-231.
2.Agoston G, Gargani L, Miglioranza MH, Caputo M, Badano LP, Moreo A, Muraru D, Mondillo S, Moggi Pignone A, Matucci Cerinic M, Sicari R, Picano E, Varga A. Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. Cardiovasc Ultrasound. 2014 Aug 5;12:30.
3.Durmus E, Sunbul M, Tigen K, Kivrak T, Ozen G, Sari I, Direskeneli H, Basaran Y. Right ventricular and atrial functions in systemic sclerosis patients without pulmonary hypertension. Speckle-tracking echocardiographic study. Herz. 2015 Jun;40(4):709-15.
4.Guerra F, Stronati G, Fischietti C, Ferrarini A, Zuliani L, Pomponio G, Capucci A, Danieli MG, Gabrielli A. Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis. Eur J Prev Cardiol. 2018 Oct;25(15):1598-1606.
5.Saito M, Wright L, Negishi K, Dwyer N, Marwick TH. Mechanics and prognostic value of left and right ventricular dysfunction in patients with systemic sclerosis. Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):660-667.
6. Hajsadeghi S, Mirshafiee S, Pazoki M, Moradians V, Mansouri P, Kianmehr N, Iranpour A. The relationship between global longitudinal strain and pulmonary function tests in patients with scleroderma and normal ejection fraction and pulmonary artery pressure: a case-control study. Int J Cardiovasc Imaging. 2020 May;36(5):883-888.
7.Spethmann S, Dreger H, Schattke S, Riemekasten G, Borges AC, Baumann G, Knebel F. Two-dimensional speckle tracking of the left ventricle in patients with systemic sclerosis for an early detection of myocardial involvement. Eur Heart J Cardiovasc Imaging. 2012 Oct;13(10):863-70.
To close complex MHs, different options have been described in different small series which pioneered various adjuvants : mainly fresh or lyophilized human amniotic membrane (AM) transplantation either transplanted into the subretinal space1-3 either put in epiretinal position4,5, autologous or allogenic lens capsular (ALC) flap transplantation inside6 or over7 the MH, autologous neurosensory retinal (ANR) free flap transplantation8.
We would like to discuss several points with the authors, referring to additional references:
1/ First, the cut off of 400 μm chosen to include high myopia macular hole retinal detachment (HMMHRD), is questionable as most of the time HMMHRD are associated with extra-large macular holes (MH) (>>400 μm) with a various amount of sub retinal fluid (SRF). The authors could have chosen another cut off to increase extrapolation of their future findings, according to the trends of new classifications. Based on the closure rate and the functional results, some authors proposed to update the International Vitreomacular Traction Study group9, as Steel et al.10 with MH>500 μm, or Ch’ng et al.11 with MH>650 μm, or Rezende et al.12 with MH>800 μm, and so use new surgical techniques such as ILM or ALC flap or ANR transplantation : why do not choose the cut off of 500 or 650 μm to include HMMHRD patients for the proposed trial? For the sample size calculation, the closure rate chosen in the control group (65%) is questionable rega...
To close complex MHs, different options have been described in different small series which pioneered various adjuvants : mainly fresh or lyophilized human amniotic membrane (AM) transplantation either transplanted into the subretinal space1-3 either put in epiretinal position4,5, autologous or allogenic lens capsular (ALC) flap transplantation inside6 or over7 the MH, autologous neurosensory retinal (ANR) free flap transplantation8.
We would like to discuss several points with the authors, referring to additional references:
1/ First, the cut off of 400 μm chosen to include high myopia macular hole retinal detachment (HMMHRD), is questionable as most of the time HMMHRD are associated with extra-large macular holes (MH) (>>400 μm) with a various amount of sub retinal fluid (SRF). The authors could have chosen another cut off to increase extrapolation of their future findings, according to the trends of new classifications. Based on the closure rate and the functional results, some authors proposed to update the International Vitreomacular Traction Study group9, as Steel et al.10 with MH>500 μm, or Ch’ng et al.11 with MH>650 μm, or Rezende et al.12 with MH>800 μm, and so use new surgical techniques such as ILM or ALC flap or ANR transplantation : why do not choose the cut off of 500 or 650 μm to include HMMHRD patients for the proposed trial? For the sample size calculation, the closure rate chosen in the control group (65%) is questionable regarding literature mentioned above, particularly when considering the cut off of 400 μm chosen for MH inclusion.
2/ Second, the question of “to fill or not fill the MH” is currently unsolved : the aim is the best functional result and not only focus on the anatomical result with a MH closure. Cover and not fill the MH is less popular in real life or in published series, as it is often harder to cover the MH with an adjuvant and ensure no displacement of this adjuvant. Recent papers showed epiretinal position of ILM flap13,14 , resulted in significantly better recovery of photoreceptor layers (fewer ELM and EZ defects), and thus visual recovery. Thus, we wanted to know why Gong Q et al. did not present their study protocol with 4 arms : covering HMMHRD with ILM or ALC, and filling HMMHRD with ILM or ALC. Besides it could be interesting for the readers, to explain why tamponade chosen is systematically high viscosity silicone oil.
3/ Third, regarding potential per-operative issues for this adjuvant, the authors could have re-use our published tips and tricks using round autologous anterior lens capsules7 : graft preparation outside the eye to reduce potential complications such as light toxicity with more handling if trimming is done in the vitreous cavity, or remnants of ALC after trimming in the vitreous cavity; advantages of circular transplant (punched or femtosecond laser cut) combining circular shape and adapted size with quite large overlapping could be the key to avoid primary ALC displacement (if overlay is performed) synonymous with surgical failure; “no touch” technique for insertion in the vitreous cavity.
We really appreciate if Gong Q et al. could adjust their interesting study protocol: it should be discussed with a clear rationale to put all issues related to the treatment of complex MHs into perspective, in order to achieve a very efficient clinical trial for retina specialists community.
1 Rizzo, S. et al. A Human Amniotic Membrane Plug to Promote Retinal Breaks Repair and Recurrent Macular Hole Closure. Retina 39 Suppl 1, S95-S103 (2019). https://doi.org:10.1097/IAE.0000000000002320
2 Abouhussein, M. A., Elbaha, S. M. & Aboushousha, M. Human Amniotic Membrane Plug for Macular Holes Coexisting with Rhegmatogenous Retinal Detachment. Clinical ophthalmology 14, 2411-2416 (2020). https://doi.org:10.2147/OPTH.S272060
3 Huang, Y. H., Tsai, D. C., Wang, L. C. & Chen, S. J. Comparison between Cryopreserved and Dehydrated Human Amniotic Membrane Graft in Treating Challenging Cases with Macular Hole and Macular Hole Retinal Detachment. Journal of ophthalmology 2020, 9157518 (2020). https://doi.org:10.1155/2020/9157518
4 Moharram, H. M., Moustafa, M. T., Mortada, H. A. & Abdelkader, M. F. Use of Epimacular Amniotic Membrane Graft in Cases of Recurrent Retinal Detachment Due to Failure of Myopic Macular Hole Closure. Ophthalmic Surg Lasers Imaging Retina 51, 101-108 (2020). https://doi.org:10.3928/23258160-20200129-06
5 Garcin, T., Gain, P. & Thuret, G. Epiretinal large disc of blue-stained lyophilized amniotic membrane to treat complex macular holes: a 1-year follow-up. Acta ophthalmologica 100, e598-e608 (2022). https://doi.org:10.1111/aos.14909
6 Chen, S. N. & Yang, C. M. Lens Capsular Flap Transplantation in the Management of Refractory Macular Hole from Multiple Etiologies. Retina 36, 163-170 (2016). https://doi.org:10.1097/IAE.0000000000000674
7 Garcin, T., Gain, P. & Thuret, G. Femtosecond laser-cut autologous anterior lens capsule transplantation to treat refractory macular holes. Eye (2022). https://doi.org:10.1038/s41433-022-02062-x
8 Grewal, D. S. & Mahmoud, T. H. Autologous Neurosensory Retinal Free Flap for Closure of Refractory Myopic Macular Holes. JAMA ophthalmology 134, 229-230 (2016). https://doi.org:10.1001/jamaophthalmol.2015.5237
9 Duker, J. S. et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120, 2611-2619 (2013). https://doi.org:10.1016/j.ophtha.2013.07.042
10 Steel, D. H. et al. Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort. Eye (2020). https://doi.org:10.1038/s41433-020-0844-x
11 Ch'ng, S. W. et al. The Manchester Large Macular Hole Study: Is it Time to Reclassify Large Macular Holes? American journal of ophthalmology 195, 36-42 (2018). https://doi.org:10.1016/j.ajo.2018.07.027
12 Rezende, F. A. et al. Surgical classification for large macular hole: based on different surgical techniques results: the CLOSE study group. Int J Retina Vitreous 9, 4 (2023). https://doi.org:10.1186/s40942-022-00439-4
13 Park, J. H., Lee, S. M., Park, S. W., Lee, J. E. & Byon, I. S. Comparative analysis of large macular hole surgery using an internal limiting membrane insertion versus inverted flap technique. Br J Ophthalmol 103, 245-250 (2019). https://doi.org:10.1136/bjophthalmol-2017-311770
14 Rossi, T. et al. Macular hole closure patterns: an updated classification. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 258, 2629-2638 (2020). https://doi.org:10.1007/s00417-020-04920-4
Dear Editor,
We have read with great interest the scoping review by Lee et al.[1], investigating efforts to integrate eye care into healthcare systems in low-income and middle-income countries (LMIC). We also share a belief in the importance of further integrating service delivery in this area.
Most of the cited studies addressed the integration of eye care into wider healthcare settings. The review highlights improved outcomes in management of retinopathy of prematurity achieved through enhancements to paediatrician-led care [2]. Furthermore, the review displays how improved provision of resources, training and enhanced engagement with other stakeholders has resulted in improved knowledge and guideline usage in primary care [3].
The review highlighted various interventions delivered as short training sessions or educational modules [4-6]. Whilst undeniably important for capacity building, these measures cannot in and of themselves achieve a highly integrated system, which would require changes in infrastructure, guidelines and referral systems.
We would appreciate a further understanding of the authors’ rationale for including certain studies in the review, which appear to contain remote or indirect references to eye care service delivery [7-12]. Some included studies [11, 12] appear to link improved management of hypertension and diabetes with prevention of associated retinopathy, though the articles do not appear to mention diabetic retinopathy e...
Dear Editor,
We have read with great interest the scoping review by Lee et al.[1], investigating efforts to integrate eye care into healthcare systems in low-income and middle-income countries (LMIC). We also share a belief in the importance of further integrating service delivery in this area.
Most of the cited studies addressed the integration of eye care into wider healthcare settings. The review highlights improved outcomes in management of retinopathy of prematurity achieved through enhancements to paediatrician-led care [2]. Furthermore, the review displays how improved provision of resources, training and enhanced engagement with other stakeholders has resulted in improved knowledge and guideline usage in primary care [3].
The review highlighted various interventions delivered as short training sessions or educational modules [4-6]. Whilst undeniably important for capacity building, these measures cannot in and of themselves achieve a highly integrated system, which would require changes in infrastructure, guidelines and referral systems.
We would appreciate a further understanding of the authors’ rationale for including certain studies in the review, which appear to contain remote or indirect references to eye care service delivery [7-12]. Some included studies [11, 12] appear to link improved management of hypertension and diabetes with prevention of associated retinopathy, though the articles do not appear to mention diabetic retinopathy explicitly.
A previous scoping review [13] concerns integrating eye health into primary healthcare in Africa, and makes wide-ranging points regarding changes to guidelines, protocols, governance, equipment and leadership – this literature may have been useful to reference in the current article.
The review by Lee et al. [1] highlights a few examples of successful integration of vision care into primary healthcare. This is understandable, given the significant pressures faced by primary healthcare globally. An alternative may be to explore integrating primary healthcare services into existing vision care platforms.
India, for example, has arguably the highest cataract surgical rate (CSR) of any lower- middle-income country, rivalling many high-income countries at 6000/million population/year. This salient strength of the healthcare system could potentially be leveraged in order to build capacity for the delivery of primary health care. Excellent eye care networks are available in India through organisations such as L V Prasad Eye Institute (LVPEI) and Aravind Eye Care[14][15]. LVPEI consists of 282 centres that provide extensive coverage, including remote and rural communities. LVPEI has a self-sustaining financial model, and the majority of patients have their care provided free of cost [15]. This excess capacity could potentially be harnessed not only to help support the delivery of primary care, but potentially to incentivise acceptance of care for chronic conditions through delivery of free eye care.
One key service for vision centres to deliver may be screening of non-communicable diseases (NCDs). Low-cost and rapid screening of blood pressure, fingerstick blood glucose, hearing and dental health could all be undertaken in existing vision centres. Furthermore, there lies the potential for eye care providers to ask for demonstrable proof of adherence to NCD care regimens as advised by medical professionals, and for this to be treated as a prerequisite for provision of vision care that is free of charge.
Several challenges must be overcome for this integration to be successfully implemented. There is a strong need to prove that adoption of these additional services by vision centres will not overburden the system and pose a threat to the sustainability of these networks. There is a need to identify the key priorities of care needed in each community and focus integration efforts on tackling the aspects of care that are most required. Additionally, high-quality trials would be needed, assessing community involvement and uptake of services under a new model of integration.
1. Lee, L., et al., Integrating eye care in low-income and middle-income settings: a scoping review. BMJ Open, 2023. 13(5): p. e068348.
2. Jacoby, M.R. and L. Du Toit, Screening for retinopathy of prematurity in a provincial hospital in Port Elizabeth, South Africa. S Afr Med J, 2016. 106(6).
3. Lilian, R.R., et al., Strengthening primary eye care in South Africa: An assessment of services and prospective evaluation of a health systems support package. PLoS One, 2018. 13(5): p. e0197432.
4. Mafwiri, M.M., et al., Mixed methods evaluation of a primary eye care training programme for primary health workers in Morogoro Tanzania. BMC Nurs, 2016. 15: p. 41.
5. Mafwiri, M.M., R. Kisenge, and C.E. Gilbert, A pilot study to evaluate incorporating eye care for children into reproductive and child health services in Dar-es-Salaam, Tanzania: a historical comparison study. BMC Nurs, 2014. 13: p. 15.
6. Malik, A.N.J., et al., Integrating eye health training into the primary child healthcare programme in Tanzania: a pre-training and post-training study. BMJ Paediatr Open, 2020. 4(1): p. e000629.
7. Ajay, V.S., et al., Development of a Smartphone-Enabled Hypertension and Diabetes Mellitus Management Package to Facilitate Evidence-Based Care Delivery in Primary Healthcare Facilities in India: The mPower Heart Project. J Am Heart Assoc, 2016. 5(12).
8. Abebe, A.M., M.W. Kassaw, and F.A. Mengistu, Assessment of Factors Affecting the Implementation of Integrated Management of Neonatal and Childhood Illness for Treatment of under Five Children by Health Professional in Health Care Facilities in Yifat Cluster in North Shewa Zone, Amhara Region, Ethiopia. Int J Pediatr, 2019. 2019: p. 9474612.
9. Carnell, M.A., et al., Effectiveness of scaling up the 'three pillars' approach to accelerating MDG 4 progress in Ethiopia. J Health Popul Nutr, 2014. 32(4): p. 549-63.
10. Jimenez Carrillo, M., et al., Comprehensive primary health care and non-communicable diseases management: a case study of El Salvador. International Journal for Equity in Health, 2020. 19(1): p. 50.
11. Lall, D., et al., Improving primary care for diabetes and hypertension: findings from implementation research in rural South India. BMJ Open, 2020. 10(12): p. e040271.
12. Lebina, L., et al., Process evaluation of implementation fidelity of the integrated chronic disease management model in two districts, South Africa. BMC Health Serv Res, 2019. 19(1): p. 965.
13. du Toit, R., et al., Evidence for integrating eye health into primary health care in Africa: a health systems strengthening approach. BMC Health Services Research, 2013. 13(1): p. 102.
14. Mehta MC, Narayanan R, Thomas Aretz H, Khanna R, Rao GN. The L V Prasad Eye Institute: A comprehensive case study of excellent and equitable eye care. Healthc (Amst). 2020 Mar;8(1):100408. doi: 10.1016/j.hjdsi.2019.100408. Epub 2020 Jan 14. PMID: 31948870.
15. Namperumalsamy P. Maintaining quality in community eye care - The Aravind model. Indian J Ophthalmol. 2020 Feb;68(2):285-287.
We read with interest Pathmanathan and Snelling’s deep exploration of the reasons that doctors leave UK medicine.[1] Considering all the negative ‘push’ factors provoking doctors to leave careers that they have spent years building, is a somewhat depressing (though compelling) read. As we consider what clinicians, policy-makers and medical educators should do with this information, it is important to reflect on another side to this story: Why do doctors ever stay in the profession?
Despite the cited problems, every year the majority of doctors do decide to stay. Is this due to loyalty to the profession, or perhaps to our patients? Is it simply a lack of imagination to consider what else we might do? Is it too hard to walk away from careers that we have invested so much of ourselves into (the sunk-cost effect[2])? Or perhaps, as the authors of the article allude to, our sense of identity is so intertwined with ’being a doctor’[3] that it is impossible to walk away without leaving a piece of ourselves behind.
While the insights from this paper do give stakeholders food for thought, we propose that it is also imperative to seek the views of those who choose to remain in UK medicine. We may be able to use these insights to help strengthen the reasons to stay in a profession that many of us consider a ‘calling’.[4]
References
1 Pathmanathan A, Snelling I. Exploring reasons behind UK doctors leaving the medical profession: a series of qualitativ...
We read with interest Pathmanathan and Snelling’s deep exploration of the reasons that doctors leave UK medicine.[1] Considering all the negative ‘push’ factors provoking doctors to leave careers that they have spent years building, is a somewhat depressing (though compelling) read. As we consider what clinicians, policy-makers and medical educators should do with this information, it is important to reflect on another side to this story: Why do doctors ever stay in the profession?
Despite the cited problems, every year the majority of doctors do decide to stay. Is this due to loyalty to the profession, or perhaps to our patients? Is it simply a lack of imagination to consider what else we might do? Is it too hard to walk away from careers that we have invested so much of ourselves into (the sunk-cost effect[2])? Or perhaps, as the authors of the article allude to, our sense of identity is so intertwined with ’being a doctor’[3] that it is impossible to walk away without leaving a piece of ourselves behind.
While the insights from this paper do give stakeholders food for thought, we propose that it is also imperative to seek the views of those who choose to remain in UK medicine. We may be able to use these insights to help strengthen the reasons to stay in a profession that many of us consider a ‘calling’.[4]
References
1 Pathmanathan A, Snelling I. Exploring reasons behind UK doctors leaving the medical profession: a series of qualitative interviews with former UK doctors. BMJ Open. 2023;13:e068202.
2 Arkes HR, Blumer C. The psychology of sunk cost. Organ Behav Hum Decis Process. 1985;35:124–40.
3 Van Dormael M, Dugas S, Kone Y, et al. Appropriate training and retention of community doctors in rural areas: a case study from Mali. Hum Resour Health. 2008;6:25.
4 Kao AC, Jager AJ. Medical students’ views of medicine as a calling and selection of a primary care-related residency. The Annals of Family Medicine. 2018;16:59–61.
In this review paper on the accuracy of gut feeling in diagnosing cancer in primary care, the authors conclude that “the findings support the continued and expanded use of gut feeling items in UK cancer referral pathways”. Whilst most clinicians will have experienced the gut feeling that their patient has a serious illness and be thankful for having done so, there is debate over what a gut feeling is and what it represents within the diagnostic process. Is it a subjective intuitive experience, or an objective recognition and response to an abnormal finding? In our teaching programme on ways to prevent diagnostic errors, we discuss the role that gut feeling has in the prevention of these errors through subconsciously alerting the clinician to the presence of an abnormal finding that has not been recognised by the cognitive part of the diagnostic process, or responded to by the clinician. To help explain this, gut feeling is conceptualised as representing a “twitch” of the clinician’s “medical antennae”.
The basis for this concept is as follows: All clinicians possess a set of medical antennae that twitch in response to an abnormal finding. Medical antennae function within the dual-process diagnostic reasoning model, where they monitor information as it is being gathered and processed. Their role within the diagnostic process is to act as a back-up warning system to alert the clinician to an abnormal finding that has not been recognised or responded to. It is postula...
In this review paper on the accuracy of gut feeling in diagnosing cancer in primary care, the authors conclude that “the findings support the continued and expanded use of gut feeling items in UK cancer referral pathways”. Whilst most clinicians will have experienced the gut feeling that their patient has a serious illness and be thankful for having done so, there is debate over what a gut feeling is and what it represents within the diagnostic process. Is it a subjective intuitive experience, or an objective recognition and response to an abnormal finding? In our teaching programme on ways to prevent diagnostic errors, we discuss the role that gut feeling has in the prevention of these errors through subconsciously alerting the clinician to the presence of an abnormal finding that has not been recognised by the cognitive part of the diagnostic process, or responded to by the clinician. To help explain this, gut feeling is conceptualised as representing a “twitch” of the clinician’s “medical antennae”.
The basis for this concept is as follows: All clinicians possess a set of medical antennae that twitch in response to an abnormal finding. Medical antennae function within the dual-process diagnostic reasoning model, where they monitor information as it is being gathered and processed. Their role within the diagnostic process is to act as a back-up warning system to alert the clinician to an abnormal finding that has not been recognised or responded to. It is postulated that antennae twitch is a subconscious response to a finding that is not present within the normal pattern of illness for a minor illness, or one that is present within the typical, atypical, or early pattern of a serious illness. Antennae twitch is experienced by the clinician as a feeling of unease, prompting a review the patient’s findings to establish the cause of this feeling. Therefore, antennae twitch is a subjective response to an objective finding. This establishes the important principle that the performance of the medical antennae is determined by the clinician’s knowledge of those findings, the sensitivity of the clinician’s antennae and the responsivity of the clinician.
Antennae performance, sensitivity and responsivity are important because they introduce the concept that there are factors that may positively and negatively affect whether a clinician experiences a gut feeling. For example, since antennae twitch is a response to a specific finding, learning what those specific findings are increases the likelihood that a twitch will occur. Conversely, if the clinician has not learned about or encountered one of those findings previously, they cannot experience a twitch. Antennae sensitivity and clinician responsivity can be compromised by both internal and external factors, such as tiredness, illness, mood disorders, workload, distractions and burn-out, resulting in “antennae droop”. Learning how to recognise and manage these periods of increased diagnostic risk safely has the potential to reduce the risk of diagnostic errors during consultations.
There are 4 ways in which the concept of medical antennae can contribute to the debate about gut feeling. Firstly, it postulates a mechanism by which gut feeling works in alerting the clinician to an abnormal finding. Secondly, it highlights the important role that gut feeling plays in identifying patients with serious illness and in preventing diagnostic errors. Thirdly, it treats gut feeling as a diagnostic tool, inferring that its performance can be enhanced through focused learning and the use of strategies to manage antennae droop safely. Finally, it is hoped that it will serve to stimulate further debate and research into whether gut feeling can be regarded as a diagnostic tool and taught as a diagnostic skill.
Pigott and colleagues, in previous criticism of the STAR*D study [1,2], identified deviations from prespecified protocolised measures of remission and response rates, mid-study eligibility criteria adjustments, and other methodological issues. In their new re-analysis, they calculate that STAR*D’s cumulative remission rates are half those originally reported [3].
Antidepressant medication remains the mainstay treatment of depression and is an optional first-line treatment for people with less severe depression [4]. This is despite a well-established effect size of around d=0.3, equivalent to approximately 2 points on the HAMD-17, which is deemed below the threshold for clinically significant improvement [5,6]. Antidepressant use continues to increase, with 15% of the UK population currently receiving an antidepressant prescription [7]. This is against a backdrop of increasing awareness of the potential harms of antidepressant medication [6], yielding new guidance published earlier this year in the British Journal of General Practice [8].
Pigott and colleagues’ findings should again prompt urgent investment into alternative efficacious treatments and research into better and novel multidisciplinary treatments, which draw on the synergy between biological, social, and psychological interventions.
Furthermore, in light of these determinations, regulatory authorities and drug developers should re-examine the line of pharmacotherapy at which novel t...
Pigott and colleagues, in previous criticism of the STAR*D study [1,2], identified deviations from prespecified protocolised measures of remission and response rates, mid-study eligibility criteria adjustments, and other methodological issues. In their new re-analysis, they calculate that STAR*D’s cumulative remission rates are half those originally reported [3].
Antidepressant medication remains the mainstay treatment of depression and is an optional first-line treatment for people with less severe depression [4]. This is despite a well-established effect size of around d=0.3, equivalent to approximately 2 points on the HAMD-17, which is deemed below the threshold for clinically significant improvement [5,6]. Antidepressant use continues to increase, with 15% of the UK population currently receiving an antidepressant prescription [7]. This is against a backdrop of increasing awareness of the potential harms of antidepressant medication [6], yielding new guidance published earlier this year in the British Journal of General Practice [8].
Pigott and colleagues’ findings should again prompt urgent investment into alternative efficacious treatments and research into better and novel multidisciplinary treatments, which draw on the synergy between biological, social, and psychological interventions.
Furthermore, in light of these determinations, regulatory authorities and drug developers should re-examine the line of pharmacotherapy at which novel treatments are considered for use in depression clinical trials. While trials of novel treatments have predominantly focused on patients unsuccessfully treated with two or more antidepressants [9, 10], these findings present the possibility that far greater numbers of patients may benefit from alternative efficacious treatments at an earlier stage of their condition. This has been on the basis that to attempt novel pharmacotherapies of undetermined efficacy, in lieu of effective licensed medication, would be unethical. However, this paper demonstrates that what were already only modest rates of remission, after trialling one antidepressant in STAR*D [11], are likely to be even less promising.
1. Pigott HE. The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression. Can J Psychiatry. 2015 Jan;60(1):9-13. doi: 10.1177/070674371506000104. PMID: 25886544; PMCID: PMC4314062.
2. Pigott, H.. (2011). STAR*D: A tale and trail of bias. Ethical Human Psychology and Psychiatry. 13. 6-28. 10.1891/1559-4343.13.1.6.
3. Pigott, H. E., Kim, T., Xu, C., Kirsch, I., & Amsterdam, J. (2023). What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR* D study’s patient-level data with fidelity to the original research protocol. BMJ open, 13(7), e063095.
5. Hengartner MP, Plöderl M. Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter! Front Psychiatry. 2018 Oct 17;9:517. doi: 10.3389/fpsyt.2018.00517. PMID: 30386270; PMCID: PMC6199395.
6. Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL, Krogh J, Ebert SE, Timm A, Lindschou J, Gluud C. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017 Feb 8;17(1):58. doi: 10.1186/s12888-016-1173-2. Erratum in: BMC Psychiatry. 2017 May 3;17 (1):162. PMID: 28178949; PMCID: PMC5299662.
7. The Pharmaceutical Journal, PJ, July 2022, Vol 309, No 7963;309(7963)::DOI:10.1211/PJ.2022.1.149158
8. Withdrawing from SSRI antidepressants: advice for primary care Emilia G Palmer, Sangeetha Sornalingam, Lisa Page, Maxwell Cooper British Journal of General Practice 2023; 73 (728): 138-140. DOI: 10.3399/bjgp23X732273
9. Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443. PMID: 36322843.
10. Daly EJ, Singh JB, Fedgchin M, Cooper K, Lim P, Shelton RC, Thase ME, Winokur A, Van Nueten L, Manji H, Drevets WC. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2018 Feb 1;75(2):139-148. doi: 10.1001/jamapsychiatry.2017.3739. PMID: 29282469; PMCID: PMC5838571.
11. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M; STAR*D Study Team. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006 Mar 23;354(12):1231-42. doi: 10.1056/NEJMoa052963. PMID: 16554525.
We thank the authors for their interest in our study. The authors highlight the considerable proportion of cases being identified by a single informant as a problem for data quality. However, this is not unusual considering that suicides and attempted suicides are associated with high stigma and hence there is very little discussion in the community. Most of these single informants were public health workers (Health or ICDS or Asha workers) who regularly visit and interact with families. Hence, they are more likely to have knowledge of events such as attempted suicide and suicides which are not otherwise in the public domain for other community informants. We have also conducted additional validity exercises where cases reported by single informants were cross-checked with the records maintained by Talati (village revenue officers) to ascertain the accuracy of the reported data.
We agree with the authors that further studies in other geographic locations will be ideal to identify the challenges in scaling up the surveillance system to the entire country.
We also agree with the authors that some legislative or policy measures to mandate data sharing by private health institutions are needed for effective implementation of community surveillance.
We agree with the authors when data on police records for suicidal attempts is n= 0 cases, the post hoc McNemar’s test is not the most appropriate statistical measure. Where we say “Whereas there was statistical ev...
We thank the authors for their interest in our study. The authors highlight the considerable proportion of cases being identified by a single informant as a problem for data quality. However, this is not unusual considering that suicides and attempted suicides are associated with high stigma and hence there is very little discussion in the community. Most of these single informants were public health workers (Health or ICDS or Asha workers) who regularly visit and interact with families. Hence, they are more likely to have knowledge of events such as attempted suicide and suicides which are not otherwise in the public domain for other community informants. We have also conducted additional validity exercises where cases reported by single informants were cross-checked with the records maintained by Talati (village revenue officers) to ascertain the accuracy of the reported data.
We agree with the authors that further studies in other geographic locations will be ideal to identify the challenges in scaling up the surveillance system to the entire country.
We also agree with the authors that some legislative or policy measures to mandate data sharing by private health institutions are needed for effective implementation of community surveillance.
We agree with the authors when data on police records for suicidal attempts is n= 0 cases, the post hoc McNemar’s test is not the most appropriate statistical measure. Where we say “Whereas there was statistical evidence of a difference (p<0.01) between community surveillance and police records, and hospital records and police records” we should actually have said “Whereas the further statistical difference between community surveillance and police records, and hospital records and police records could not be tested as there were zero cases recorded by police”.
We did not explore alternative approaches such as imputing missing values as we are not certain that using imputation for real time data on suicides is an appropriate method for dealing with missing values.
Yang et al. conducted a meta-analysis of randomised controlled trials (RCTs) to investigate the effect of continuous positive airway pressure (CPAP) treatment on cognitive function in stroke patients with obstructive sleep apnoea (OSA) (1). There were no significant effects on global cognitive gain in stroke patients with OSA, although an early start within 2 weeks post stroke of CPAP treatment after stroke significantly improved global cognition. Additionally, CPAP did not significantly improve memory, language, attention or executive function. Stroke event itself may be a risk of poor cognitive function, and there is a need of understanding the clinical benefits of CPAP treatment on cognitive function in subjects without stroke history. I present information regarding the relationship between CPAP treatment and cognitive impairment with special reference to baseline state of cognitive function and CPAP adherence.
First, there was insufficient evidence to suggest that treating sleep dysfunction can improve cognition by a meta-analysis of RCTs (2). Yang et al. should consider the severity of stroke for the analysis, although stroke itself might contribute to the level of cognitive function.
Second, Hoyos et al. evaluated the cognitive benefits by CPAP treatment in patients with OSA and mild cognitive impairment (MCI) (3). The authors conducted RCT study to specify the causal association, and CPAP treatment was significantly associated with improvements in P...
Yang et al. conducted a meta-analysis of randomised controlled trials (RCTs) to investigate the effect of continuous positive airway pressure (CPAP) treatment on cognitive function in stroke patients with obstructive sleep apnoea (OSA) (1). There were no significant effects on global cognitive gain in stroke patients with OSA, although an early start within 2 weeks post stroke of CPAP treatment after stroke significantly improved global cognition. Additionally, CPAP did not significantly improve memory, language, attention or executive function. Stroke event itself may be a risk of poor cognitive function, and there is a need of understanding the clinical benefits of CPAP treatment on cognitive function in subjects without stroke history. I present information regarding the relationship between CPAP treatment and cognitive impairment with special reference to baseline state of cognitive function and CPAP adherence.
First, there was insufficient evidence to suggest that treating sleep dysfunction can improve cognition by a meta-analysis of RCTs (2). Yang et al. should consider the severity of stroke for the analysis, although stroke itself might contribute to the level of cognitive function.
Second, Hoyos et al. evaluated the cognitive benefits by CPAP treatment in patients with OSA and mild cognitive impairment (MCI) (3). The authors conducted RCT study to specify the causal association, and CPAP treatment was significantly associated with improvements in Pittsburgh sleep quality index, verbal learning and memory retention, which was inconsistent with data by Yang et al. Although the number of samples is limited, CPAP treatment suppressed the progression of cognitive impairment.
Finally, Liguori et al. evaluated the long-term effects of CPAP treatment in 24 patients with OSA and MCI (n=8) or Alzheimer's disease (AD: n=16) (4). There was a significant difference in cognitive and functional performances assessed with clinical dementia rating (CDR) scale between the CPAP non-adherent and adherent groups, presenting worse cognitive and functional performances in patients with CPAP non-adherent group. Although there were clinical advantages of CPAP treatment to delay cognitive deterioration in patients with MCI or AD, adherence to CPAP treatment may be a key factor to achieve risk reduction in the progression of cognitive impairment. Dunietz et al. also reported that PAP adherence was significantly associated with lower odds of incident diagnoses of AD (5). These two papers adopted a retrospective cohort study design, and RCTs are needed to specify the causal relationship.
References
1. Yang Y, Wu W, Huang H, et al. Effect of CPAP on cognitive function in stroke patients with obstructive sleep apnoea: a meta-analysis of randomised controlled trials. BMJ Open 2023;13(1):e060166.
2. Franks KH, Rowsthorn E, Nicolazzo J, et al. The treatment of sleep dysfunction to improve cognitive function: A meta-analysis of randomized controlled trials. Sleep Med 2023;101:118-26.
3. Hoyos CM, Cross NE, Terpening Z, et al. Continuous positive airway pressure for cognition in sleep apnea and mild cognitive impairment: A pilot randomized crossover clinical trial. Am J Respir Crit Care Med 2022;205(12):1479-82.
4. Liguori C, Cremascoli R, Maestri M, et al. Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? Sleep Breath 2021;25(4):2135-9.
5. Dunietz GL, Chervin RD, Burke JF, et al. Obstructive sleep apnea treatment and dementia risk in older adults. Sleep 2021;44(9):zsab076.
BACKGROUND
This update relates to the study protocol for “Can a teacher-led mindfulness intervention for new school entrants improve child outcomes? Protocol for a school cluster randomised controlled trial”
Mindfulness-based approaches have been shown to be effective in improving the outcomes for adults, with emerging evidence for adolescents and children. However, the majority of these interventions have not been evaluated through controlled trials to understand their effectiveness and cost-effectiveness. Furthermore, fewer studies have examined mindfulness intervention using play-based activities and targeting teacher practice to ensure practices are sustained over time. To address this gap, the design was a cluster randomised controlled trial in primary schools (clusters), with schools randomised to either the Minds@Play intervention or ‘business as usual (control). This study aims to contribute to the evidence related to the effectiveness and cost-effectiveness of whether a mindfulness intervention is able to provide outcomes for students, and the implementation factors which may influence the outcomes observed.
Several changes to the original study protocol were made to reflect learnings from the set up and conduct of the study, as well as reflect the government-mandated restrictions in Melbourne, Victoria, where the study was conducted.
In Melbourne, Australia – where the study was based – there were a numbe...
BACKGROUND
This update relates to the study protocol for “Can a teacher-led mindfulness intervention for new school entrants improve child outcomes? Protocol for a school cluster randomised controlled trial”
Mindfulness-based approaches have been shown to be effective in improving the outcomes for adults, with emerging evidence for adolescents and children. However, the majority of these interventions have not been evaluated through controlled trials to understand their effectiveness and cost-effectiveness. Furthermore, fewer studies have examined mindfulness intervention using play-based activities and targeting teacher practice to ensure practices are sustained over time. To address this gap, the design was a cluster randomised controlled trial in primary schools (clusters), with schools randomised to either the Minds@Play intervention or ‘business as usual (control). This study aims to contribute to the evidence related to the effectiveness and cost-effectiveness of whether a mindfulness intervention is able to provide outcomes for students, and the implementation factors which may influence the outcomes observed.
Several changes to the original study protocol were made to reflect learnings from the set up and conduct of the study, as well as reflect the government-mandated restrictions in Melbourne, Victoria, where the study was conducted.
In Melbourne, Australia – where the study was based – there were a number of significant restrictions initiated by the federal and state government as part of the pandemic response. The first case in Victoria was announced on the 25th January 2020, with the Victorian government announcing on the 16th March 2020 that a state of emergency was to commence which involved capacity limitations, working from home measures and restrictions on visiting high risk settings. Over the course of 2020 and 2021, Melbourne experienced six periods of lockdown and remote learning. The two most stringent lockdowns commenced in October 2020 (111 days) and August 2021 (88 days), which included a curfew between 8PM and 6AM, a 5km travel radius limited, 1hr outdoor limitation as well as no visitors to households and no groups allowed in public. Overall, across 2020-21 Victorian students experienced 262 days of remote learning.
Given this context, the following changes were made to the original study protocol.
METHODS/DESIGNS
Changes to intervention delivery period
The participants were recruited in February/March 2020 and had not been randomised when the first lockdown was announced in March 2020, which include remote learning and all research in education settings being suspended to enable schools to focus on transitioning to remote learning delivery. Given this extended throughout 2020, the randomisation did not occur until February 2021 when an exemption was granted for the study to commence. Therefore, students were 1 year older than intended when the intervention commenced since the original design had students exposed to the intervention in Foundation (first year of elementary school) and Grade 1 (second year). Under the updated design students were still exposed to the intervention for the 2 year period, spanning Grade 1 (second year of school) in 2021 and Grade 2 (third year of school) in 2022.
For periods where there were restrictions involving remote learning (detain start and end of each 2021 lockdowns), teachers were encouraged to adapt the intervention activities for remote learning platforms. The process evaluation will enable an understanding of how the intervention was delivered during these periods.
Changes to teacher professional learning
The original design involved teachers attending a 1 day professional development which focused on providing them with the rational and theory related to mindfulness, as well as enable an opportunity to practice some of the activities in the manual. Instead, the components related to rationale and theory were developed to be online content that educators could access and go through asynchronously. The practice component was delivered in a 1-hour online webinar lead by CI Deery. Educator engagement with the online platform will be measured using metrics available in CANVAS, which is the platform used by the University to deliver usual teaching activities.
Changes to data collection, including secondary outcomes
Due to restrictions on data collection placed by the state education department, a number of activities originally planned could not be completed to lower the burden on schools and limit spread of covid during this period. This mainly influenced the ability to collect child face to face measures and teacher-reported child outcomes. In addition, a number of measures were also added to understand outcomes related to the pandemic, such as student coping skills and impact of remote learning.
Changes to the primary endpoint
The timeframe for data collection of the primary outcome for the study, child visuo-spatial short-term memory, as measured by the Corsi Block Tapping Forward Raw Score was changed from 18 months post randomisation to 24 months post randomisation to align with the funding availability and when the data collection could be completed. The updated timeline of 24 months post-randomisation now coincides with the end of the second year of the intervention delivery in schools.
Changes to sample size calculation
According to the original protocol, the estimated sample size was 413 children per condition, 826 in total, which translated into recruitment of 22 schools, assuming an average of 2.5 Foundation Year classes at each school, and an average of 16 parents providing consent for data collection in each class (65% consent rate). In February/March 2020 twenty schools were recruited (for a total of 708 children). However, at the beginning of 2021, only 15 of the originally recruited schools confirmed their participation, due to workload and stressors related to the ongoing COVID-19 pandemic. However, students at these schools continued to participate in the parent-based data collection but not the teacher or face to face data collection activities. Therefore, 498 students were available for the face to face data collection for the primary outcome.
We decided to amend the sample size statement to reflect the lower actual sample size: accounting for the clustering effect within classes (ICC=0.02) and schools (ICC=0.01), and an attrition rate of 20% by the end of the study, our sample size of 498 children in total (coming from 15 schools with an average of 3 Grade 1 classes at each school) will give us 80% power and a two-tailed 5% Type I error to detect a minimum effect size of 0.32-033 standard deviations (SD) between the treatment and control groups at 24-months post-randomization.
Final analysis plan for comparison analyses
The details of the statistical analysis will reflect the final study design and will be detailed in a comprehensive Statistical Analysis Plan that will be made publicly available on Figshare.
Dear Editor,
Thank you for providing us with the opportunity to respond to Dr. Peverill’s comment concerning our article entitled “Cardiac involvement assessment in systemic sclerosis using speckle tracking echocardiography: a systematic review and meta-analysis”. We also acknowledge and appreciate Dr. Peverill’s time spent reading our article and providing his comments to help us strengthen the article.
As proposed by Dr. Peverill and also stated in the article, our systematic review was conducted because of results from related studies were controversial. Based on the meta-analysis results, we found left ventricular (LV) global longitudinal strain (GLS) was lower in SSc patients than in healthy control subjects. We are sorry we included multiple sclerosis in the study by mistake. We will correct it as soon as possible with the help of our editors. As for the reported large standard deviation (SD) of GLS of 8.9% in the control group 1, we have carefully reviewed the article again, and this value has been mentioned many times and is difficult to identify as an error. Moreover, as suggested by Dr. Peverill, we will present the result with the study excluded in the supplementary file.
As Dr. Peverill suggests, age and sex may affect GLS. The effects of age and sex on the results of SSc and control groups need to be considered, however most studies include age- and sex- matched control groups [2-7], which may reduce the effect. In our study, we also perfor...
Show MoreTo close complex MHs, different options have been described in different small series which pioneered various adjuvants : mainly fresh or lyophilized human amniotic membrane (AM) transplantation either transplanted into the subretinal space1-3 either put in epiretinal position4,5, autologous or allogenic lens capsular (ALC) flap transplantation inside6 or over7 the MH, autologous neurosensory retinal (ANR) free flap transplantation8.
We would like to discuss several points with the authors, referring to additional references:
Show More1/ First, the cut off of 400 μm chosen to include high myopia macular hole retinal detachment (HMMHRD), is questionable as most of the time HMMHRD are associated with extra-large macular holes (MH) (>>400 μm) with a various amount of sub retinal fluid (SRF). The authors could have chosen another cut off to increase extrapolation of their future findings, according to the trends of new classifications. Based on the closure rate and the functional results, some authors proposed to update the International Vitreomacular Traction Study group9, as Steel et al.10 with MH>500 μm, or Ch’ng et al.11 with MH>650 μm, or Rezende et al.12 with MH>800 μm, and so use new surgical techniques such as ILM or ALC flap or ANR transplantation : why do not choose the cut off of 500 or 650 μm to include HMMHRD patients for the proposed trial? For the sample size calculation, the closure rate chosen in the control group (65%) is questionable rega...
Dear Editor,
Show MoreWe have read with great interest the scoping review by Lee et al.[1], investigating efforts to integrate eye care into healthcare systems in low-income and middle-income countries (LMIC). We also share a belief in the importance of further integrating service delivery in this area.
Most of the cited studies addressed the integration of eye care into wider healthcare settings. The review highlights improved outcomes in management of retinopathy of prematurity achieved through enhancements to paediatrician-led care [2]. Furthermore, the review displays how improved provision of resources, training and enhanced engagement with other stakeholders has resulted in improved knowledge and guideline usage in primary care [3].
The review highlighted various interventions delivered as short training sessions or educational modules [4-6]. Whilst undeniably important for capacity building, these measures cannot in and of themselves achieve a highly integrated system, which would require changes in infrastructure, guidelines and referral systems.
We would appreciate a further understanding of the authors’ rationale for including certain studies in the review, which appear to contain remote or indirect references to eye care service delivery [7-12]. Some included studies [11, 12] appear to link improved management of hypertension and diabetes with prevention of associated retinopathy, though the articles do not appear to mention diabetic retinopathy e...
We read with interest Pathmanathan and Snelling’s deep exploration of the reasons that doctors leave UK medicine.[1] Considering all the negative ‘push’ factors provoking doctors to leave careers that they have spent years building, is a somewhat depressing (though compelling) read. As we consider what clinicians, policy-makers and medical educators should do with this information, it is important to reflect on another side to this story: Why do doctors ever stay in the profession?
Despite the cited problems, every year the majority of doctors do decide to stay. Is this due to loyalty to the profession, or perhaps to our patients? Is it simply a lack of imagination to consider what else we might do? Is it too hard to walk away from careers that we have invested so much of ourselves into (the sunk-cost effect[2])? Or perhaps, as the authors of the article allude to, our sense of identity is so intertwined with ’being a doctor’[3] that it is impossible to walk away without leaving a piece of ourselves behind.
While the insights from this paper do give stakeholders food for thought, we propose that it is also imperative to seek the views of those who choose to remain in UK medicine. We may be able to use these insights to help strengthen the reasons to stay in a profession that many of us consider a ‘calling’.[4]
References
Show More1 Pathmanathan A, Snelling I. Exploring reasons behind UK doctors leaving the medical profession: a series of qualitativ...
In this review paper on the accuracy of gut feeling in diagnosing cancer in primary care, the authors conclude that “the findings support the continued and expanded use of gut feeling items in UK cancer referral pathways”. Whilst most clinicians will have experienced the gut feeling that their patient has a serious illness and be thankful for having done so, there is debate over what a gut feeling is and what it represents within the diagnostic process. Is it a subjective intuitive experience, or an objective recognition and response to an abnormal finding? In our teaching programme on ways to prevent diagnostic errors, we discuss the role that gut feeling has in the prevention of these errors through subconsciously alerting the clinician to the presence of an abnormal finding that has not been recognised by the cognitive part of the diagnostic process, or responded to by the clinician. To help explain this, gut feeling is conceptualised as representing a “twitch” of the clinician’s “medical antennae”.
The basis for this concept is as follows: All clinicians possess a set of medical antennae that twitch in response to an abnormal finding. Medical antennae function within the dual-process diagnostic reasoning model, where they monitor information as it is being gathered and processed. Their role within the diagnostic process is to act as a back-up warning system to alert the clinician to an abnormal finding that has not been recognised or responded to. It is postula...
Show MorePigott and colleagues, in previous criticism of the STAR*D study [1,2], identified deviations from prespecified protocolised measures of remission and response rates, mid-study eligibility criteria adjustments, and other methodological issues. In their new re-analysis, they calculate that STAR*D’s cumulative remission rates are half those originally reported [3].
Antidepressant medication remains the mainstay treatment of depression and is an optional first-line treatment for people with less severe depression [4]. This is despite a well-established effect size of around d=0.3, equivalent to approximately 2 points on the HAMD-17, which is deemed below the threshold for clinically significant improvement [5,6]. Antidepressant use continues to increase, with 15% of the UK population currently receiving an antidepressant prescription [7]. This is against a backdrop of increasing awareness of the potential harms of antidepressant medication [6], yielding new guidance published earlier this year in the British Journal of General Practice [8].
Pigott and colleagues’ findings should again prompt urgent investment into alternative efficacious treatments and research into better and novel multidisciplinary treatments, which draw on the synergy between biological, social, and psychological interventions.
Furthermore, in light of these determinations, regulatory authorities and drug developers should re-examine the line of pharmacotherapy at which novel t...
Show MoreWe thank the authors for their interest in our study. The authors highlight the considerable proportion of cases being identified by a single informant as a problem for data quality. However, this is not unusual considering that suicides and attempted suicides are associated with high stigma and hence there is very little discussion in the community. Most of these single informants were public health workers (Health or ICDS or Asha workers) who regularly visit and interact with families. Hence, they are more likely to have knowledge of events such as attempted suicide and suicides which are not otherwise in the public domain for other community informants. We have also conducted additional validity exercises where cases reported by single informants were cross-checked with the records maintained by Talati (village revenue officers) to ascertain the accuracy of the reported data.
Show MoreWe agree with the authors that further studies in other geographic locations will be ideal to identify the challenges in scaling up the surveillance system to the entire country.
We also agree with the authors that some legislative or policy measures to mandate data sharing by private health institutions are needed for effective implementation of community surveillance.
We agree with the authors when data on police records for suicidal attempts is n= 0 cases, the post hoc McNemar’s test is not the most appropriate statistical measure. Where we say “Whereas there was statistical ev...
I think you have mislabelled one of the diagnostic categories in Table 1. Irritable bowel syndrome should be "Inflammatory Bowel Disease"
Yang et al. conducted a meta-analysis of randomised controlled trials (RCTs) to investigate the effect of continuous positive airway pressure (CPAP) treatment on cognitive function in stroke patients with obstructive sleep apnoea (OSA) (1). There were no significant effects on global cognitive gain in stroke patients with OSA, although an early start within 2 weeks post stroke of CPAP treatment after stroke significantly improved global cognition. Additionally, CPAP did not significantly improve memory, language, attention or executive function. Stroke event itself may be a risk of poor cognitive function, and there is a need of understanding the clinical benefits of CPAP treatment on cognitive function in subjects without stroke history. I present information regarding the relationship between CPAP treatment and cognitive impairment with special reference to baseline state of cognitive function and CPAP adherence.
First, there was insufficient evidence to suggest that treating sleep dysfunction can improve cognition by a meta-analysis of RCTs (2). Yang et al. should consider the severity of stroke for the analysis, although stroke itself might contribute to the level of cognitive function.
Second, Hoyos et al. evaluated the cognitive benefits by CPAP treatment in patients with OSA and mild cognitive impairment (MCI) (3). The authors conducted RCT study to specify the causal association, and CPAP treatment was significantly associated with improvements in P...
Show MoreBACKGROUND
This update relates to the study protocol for “Can a teacher-led mindfulness intervention for new school entrants improve child outcomes? Protocol for a school cluster randomised controlled trial”
Mindfulness-based approaches have been shown to be effective in improving the outcomes for adults, with emerging evidence for adolescents and children. However, the majority of these interventions have not been evaluated through controlled trials to understand their effectiveness and cost-effectiveness. Furthermore, fewer studies have examined mindfulness intervention using play-based activities and targeting teacher practice to ensure practices are sustained over time. To address this gap, the design was a cluster randomised controlled trial in primary schools (clusters), with schools randomised to either the Minds@Play intervention or ‘business as usual (control). This study aims to contribute to the evidence related to the effectiveness and cost-effectiveness of whether a mindfulness intervention is able to provide outcomes for students, and the implementation factors which may influence the outcomes observed.
Several changes to the original study protocol were made to reflect learnings from the set up and conduct of the study, as well as reflect the government-mandated restrictions in Melbourne, Victoria, where the study was conducted.
In Melbourne, Australia – where the study was based – there were a numbe...
Show MorePages